Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(5):357; doi:10.1093/jnci/92.5.357
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 5, 357, March 1, 2000
© 2000 Oxford University Press

IN THIS ISSUE

Radiation Therapy and Rectal Cancer

The conviction that postoperative radiotherapy and chemotherapy represent the standard of care for patients with Dukes’ B (stage II) and Dukes’ C (stage III) carcinoma of the rectum evolved in the absence of proper clinical trials designed to determine whether the addition of radiotherapy results in improved disease-free survival and overall survival. Wolmark et al. (p. 388) addressed this issue by conducting a randomized clinical trial (National Surgical Adjuvant Breast and Bowel Project [NSABP] Protocol R-02). Eligible patients were randomly assigned to receive postoperative adjuvant . . . [Full Text of this Article]

HPV DNA Testing of Cervical Lesions

Delivery Vehicles in Gene Therapy

HER2 Gene Polymorphisms and Risk of Breast Cancer

Chemoprevention in a Mouse Mammary In Vitro Model


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?